Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-24-221103
Filing Date
2024-09-18
Accepted
2024-09-18 09:00:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d761206dsctota.htm SC TO-T/A 24526
2 EX-99.(A)(5)(E) d761206dex99a5e.htm EX-99.(A)(5)(E) 13713
3 GRAPHIC g761206dsp6.jpg GRAPHIC 20050
  Complete submission text file 0001193125-24-221103.txt   67766
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90214 | Film No.: 241306274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROERVANGSVEJ 30 HOLBAEK G7 DK-4300
Business Address ROERVANGSVEJ 30 HOLBAEK G7 DK-4300 45 5948 5959
Pharmacosmos A/S (Filed by) CIK: 0002032940 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)